LNCAROD and esophageal squamous cell carcinoma: Through RIP experiments, we validated the direct binding between YTHDC1 and LNCAROD (Figure 1N), and silencing YTHDC1 in ESCC cells significantly reduced LNCAROD level (Figure 1O and P).